BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12180107)

  • 1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
    Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
    Bone Marrow Transplant; 2002 Apr; 29(8):639-46. PubMed ID: 12180107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
    Ljungman P; Urbano-Ispizua A; Cavazzana-Calvo M; Demirer T; Dini G; Einsele H; Gratwohl A; Madrigal A; Niederwieser D; Passweg J; Rocha V; Saccardi R; Schouten H; Schmitz N; Socie G; Sureda A; Apperley J;
    Bone Marrow Transplant; 2006 Mar; 37(5):439-49. PubMed ID: 16444286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.
    Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D;
    Bone Marrow Transplant; 2010 Feb; 45(2):219-34. PubMed ID: 19584824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
    Goldman JM; Schmitz N; Niethammer D; Gratwohl A
    Bone Marrow Transplant; 1998 Jan; 21(1):1-7. PubMed ID: 9486487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
    Schmitz N; Gratwohl A; Goldman JM
    Bone Marrow Transplant; 1996 Apr; 17(4):471-7. PubMed ID: 8722341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
    Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
    Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation activity in Europe 1999.
    Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
    Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J; Baldomero H
    Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J; Baldomero H
    Bone Marrow Transplant; 1996 Feb; 17(2):137-48. PubMed ID: 8640158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.
    Gratwohl A; Schmid O; Baldomero H; Horisberger B; Urbano-Ispizua A;
    Bone Marrow Transplant; 2004 Nov; 34(10):855-75. PubMed ID: 15517006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation in Europe: trends and prospects.
    Tan SS; Uyl-de Groot CA; Huijgens PC; Fibbe WE
    Eur J Cancer; 2007 Nov; 43(16):2359-65. PubMed ID: 17919900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBMT activity survey 2004 and changes in disease indication over the past 15 years.
    Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; ;
    Bone Marrow Transplant; 2006 Jun; 37(12):1069-85. PubMed ID: 16757972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
    Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
    Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current trends in hematopoietic stem cells therapeutic use].
    Espérou H
    Rev Prat; 2008 Dec; 58(19):2130-6. PubMed ID: 19213541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.